A Phase 2, Multicenter, Single-arm Study to Evaluate the Safety and Efficacy of Enzalutamide in Chemotherapy-Naive, Symptomatic Patients With Metastatic Castration-Resistant Prostate Cancer

Trial Profile

A Phase 2, Multicenter, Single-arm Study to Evaluate the Safety and Efficacy of Enzalutamide in Chemotherapy-Naive, Symptomatic Patients With Metastatic Castration-Resistant Prostate Cancer

Withdrawn prior to enrolment
Phase of Trial: Phase II

Latest Information Update: 05 Aug 2013

At a glance

  • Drugs Enzalutamide (Primary)
  • Indications Prostate cancer
  • Focus Therapeutic Use
  • Acronyms ASPIRE
  • Most Recent Events

    • 07 Jun 2017 Biomarkers information updated
    • 20 Aug 2012 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top